Many people don't know what heparin does. Today, Heparins Manufacturer tells you about it.
Heparin sodium indications: prevent thrombosis and diffusion, reduce the occurrence of pulmonary infarction, the treatment of acute deep vein thrombosis. Prevention of left atrioventricular stenosis, congestive heart failure, left atrial enlargement, cardiomyopathy with atrial fibrillation, and cardiac valve replacement or other cardiac surgery caused by systemic embolism. Prevention of catheter-induced thromboembolism during arterial surgery and coronary angiography. Adjunctive management of acute myocardial infarction reduces thromboembolic complications. It is especially suitable for patients with myocardial infarction complicated with congestive heart failure, cardiogenic shock, long-term arrhythmia, chronic persistent atrial fibrillation, recurrent myocardial infarction, venous thrombosis or pulmonary infarction history. It reduces the risk of brain clots and mortality.
Heparins Manufacturer- Heparin sodium indication
However, it is not clear whether recurrent cerebral embolism without hemorrhage can be controlled or mortality can be reduced. Used for diffuse intravascular coagulation (DISSEMINATED intravascular coagulation), especially during periods of hypercoagulation, to reduce the depletion of clotting factors. The drug is effective in the treatment of disseminated intravascular coagulation (DIC) with the following diseases: amniotic fluid embolism, stillbirth syndrome, atypical blood transfusion reactions, fulminant purpura, sepsis, heat stroke, and metastatic cancer; But not for disseminated intravascular coagulation (DIC) caused by snakebite. As in vitro anticoagulants (e.g., blood transfusions, extracorporeal circulation, hemodialysis, peritoneal dialysis, and in vitro tests of blood samples).
It has been reported that the drug can promote the release of lipoprotein lipase (scavening factor) in tissues, which in turn catalyzes the hydrolysis of triacylglycerol, thereby clearing blood lipids. It can also enhance the inhibitory effect of antithrombin ⅲ on vascular endothelin, so as to inhibit the acute attack of hereditary angoneeurotic edema. Thrombophlebitis, thromboangiitis obliterans (Berger's disease), etc.